Johns Hopkins university this week dropped a quiet bombshell of a study that went widely ignored in the mainstream media [as always!].
Dr. Marty Makary, spearheading a team at Johns Hopkins to do the work that the CDC and NIH refuse to do, showed that 99% of unvaccinated people known to have Covid infections had robust “natural immunity” that did not diminish for at least 650 days.
Of 1580 individuals invited to undergo serologic testing, 816 (52%) did so between September 24, 2021, and November 5, 2021. Participants had a mean age of 48.0 years, 421 (52%) were women, and 669 (82%) were White (Table). Fourteen percent reported routine mask use in public. Anti-RBD and anti-N antibody presence/absence were correlated (95%; Cohen κ=0.908).
Among 295 reported COVID-confirmed participants, 293 (99%) tested positive for anti-RBD antibodies (≥250 U/mL, 44%; ≥500 U/mL, 27%; ≥1000 U/mL, 15%). A median of 8.7 (IQR, 1.9-12.9; range, 0-20) months passed since reported COVID-19 diagnosis. The median anti-RBD level among those who tested positive was 205 (IQR, 61-535) U/mL. There was no evidence of association between time after infection and antibody titer (0.8% increase [95% CI, –2.4% to 4.2%] per month, P = .62) (Figure).
Among 275 reported COVID-unconfirmed participants, 152 (55%) tested positive for anti-RBD antibodies (≥250 U/mL, 18%; ≥500 U/mL, 12%; ≥1000 U/mL, 6%). The median level among those who tested positive was 131 (IQR, 35-402) U/mL.
Among 246 reported no-COVID participants, 11% tested positive for anti-RBD antibodies (≥250 U/mL, 2%; ≥500 U/mL, 2%; ≥1000 U/mL, 2%). The median level among those who tested positive was 82 (IQR, 19-172) U/mL.
The charts included in the study reveal the story. As you can see, for three different types of important antibodies, about 95% of people with prior infections retained all three. 99% had the anti-RBD positive type of antibody.
Most importantly of all, this is clear indisputable evidence that natural immunity is far more durable than vaccinated immunity: The Covid protection lasted for 650 days with no noticeable decline.
‘This Ends The Debate’: Israeli Study Shows Natural Immunity 13x More Effective Than Vaccines At Stopping Delta.
As Becker News reported in October, Dr. Makary was leading a study that would force the CDC and NIH to do their jobs and not merely act as jjab salesmen.
My Johns Hopkins research team is leading a long-term study of natural immunity because the NIH and CDC are not doing it. They have $50 billion and 30,000 employees and yet can't seen to conduct one of the most important studies we need done to inform the public.
— Marty Makary MD, MPH (@MartyMakary) October 27, 2021
“The NIH should be doing a long-term study of natural immunity instead of torturing thousands of beagle puppies, including cutting their voice box to avoid barking sounds (sick),” he said. “All taxpayer funded. All our health agencies need fresh new leadership.”
“My Johns Hopkins research team is leading a long-term study of natural immunity because the NIH and CDC are not doing it,” he added. “They have $50 billion and 30,000 employees and yet can’t seen to conduct one of the most important studies we need done to inform the public.”
That he did. Now, even the CDC is admitting that natural immunity exists. This constitutes yet another “we told you so” in the now extremely long list that can be compiled by critics of The Science.™